Study	O
Population	O

This	O
prospective	O
longitudinal	O
study	O
was	O
conducted	O
at	O
the	O
University	O
of	O
British	O
Columbia	O
and	O
was	O
approved	O
by	O
the	O
human	O
research	O
ethics	O
board	O
at	O
that	O
institution	O
.	O

All	O
subjects	O
who	O
received	O
a	O
renal	B-Organ
transplant	I-Organ
from	O
January	O
2005	O
to	O
December	O
2007	O
were	O
invited	O
to	O
participate	O
,	O
and	O
those	O
who	O
agreed	O
and	O
signed	O
consent	O
forms	O
were	O
enrolled	O
in	O
the	O
study	O
.	O

Patients	O
were	O
followed	O
routinely	O
at	O
the	O
transplant	O
center	O
,	O
and	O
blood	B-Organism_substance
and	O
urine	B-Organism_substance
samples	I-Organism_substance
were	O
obtained	O
prior	O
to	O
and	O
serially	O
post	O
-	O
transplant	O
at	O
0	O
.	O
5	O
,	O
1	O
,	O
2	O
,	O
3	O
,	O
4	O
,	O
8	O
,	O
12	O
,	O
and	O
26	O
weeks	O
;	O
then	O
every	O
6	O
months	O
through	O
year	O
3	O
;	O
and	O
also	O
at	O
the	O
time	O
of	O
suspected	O
rejection	O
.	O

Graft	B-Tissue
biopsy	I-Tissue
tissue	I-Tissue
was	O
obtained	O
pretransplant	O
and	O
at	O
the	O
time	O
of	O
all	O
biopsies	O
performed	O
post	O
-	O
transplant	O
.	O

Blood	B-Organism_substance
samples	I-Organism_substance
from	O
normal	O
healthy	O
controls	O
served	O
as	O
reference	O
samples	B-Organism_substance
.	O

Samples	B-Organism_substance
from	O
cases	O
,	O
controls	O
,	O
and	O
comparators	O
were	O
treated	O
identically	O
.	O

All	O
rejection	O
episodes	O
were	O
diagnosed	O
by	O
conventional	O
clinical	O
and	O
laboratory	O
parameters	O
,	O
confirmed	O
by	O
biopsy	O
,	O
and	O
graded	O
according	O
to	O
the	O
Banff	O
97	O
working	O
classification	O
of	O
renal	B-Organ
allograft	I-Organ
pathology	O
(	O
28	O
)	O
.	O

Banff	O
categories	O
2	O
and	O
4	O
(	O
antibody	O
-	O
mediated	O
or	O
acute	O
/	O
active	O
cellular	B-Cell
rejection	O
)	O
were	O
considered	O
significant	O
.	O

Category	O
3	O
(	O
borderline	O
change	O
)	O
was	O
only	O
considered	O
significant	O
if	O
associated	O
with	O
graft	B-Organ
dysfunction	O
and	O
treated	O
for	O
rejection	O
.	O

All	O
baseline	O
demographic	O
and	O
follow	O
-	O
up	O
data	O
were	O
recorded	O
in	O
the	O
transplant	O
program	O
electronic	O
database	O
,	O
and	O
there	O
was	O
no	O
loss	O
to	O
follow	O
-	O
up	O
during	O
the	O
period	O
of	O
study	O
.	O

